EP3222616
N-[2-{4-[6-amínó-5-(2,4-díflúróbensóýl)-2-oxópýridín-1(2H)-YL]-3,5-díflúrófenýl}etýl]-L-alanín og terbútýlester af því
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
15.10.2013EP published:
17.7.2019EP application number:
17168533.2
EP translation filed:
9.8.2019Grant published:
15.10.2019EPO information:
European Patent Register
Max expiry date:
14.10.2033Expiry date:
14.10.2022
Title:
N-[2-{4-[6-AMINO-5-(2,4-DIFLUOROBENZOYL)-2-OXOPYRIDIN-1(2H)-YL]-3,5-DIFLUOROPHENYL}ETHYL]-L-ALANINE AND THE TERBUTYL ESTER THEREOF
Timeline
Today
15.10.2013EP application
17.7.2019EP Publication
9.8.2019Translation submitted
15.10.2019Registration published
14.10.2022Expires
Owner
Name:
MACROPHAGE PHARMA LIMITEDAddress:
St. Stephens House Arthur Road, Windsor, Berkshire SL4 1RU, GB
Inventor
Name:
PINTAT, StéphaneAddress:
London WC1N 3AX, GB
Name:
DAVIES, Stephen, JohnAddress:
London WC1N 3AX, GB
Name:
MOFFAT, David, Festus, CharlesAddress:
London WC1N 3AX, GB
Agent
Name:
Tego ehf.Address:
Pósthólf 8129, 128, Reykjavík,
Priority
Number:
201218640Date:
17.10.2012Country:
GB
Number:
201306881Date:
16.4.2013Country:
GB
Classification
Categories:
C07D 213/73, A61K 31/4412, A61P 35/00, A61P 29/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 9.9.2019
Expires: 14.10.2020
Payer: Árnason Faktor
Number: 8
Paid: 9.9.2020
Expires: 14.10.2021
Payer: Árnason Faktor ehf.
Number: 9
Paid: 7.9.2021
Expires: 14.10.2022
Payer: Árnason Faktor ehf.